Disruptive Innovations in Respiratory Devices Market

Janifha Evangeline | Friday, 17 June 2022

 Janifha Evangeline

The global respiratory devices market is anticipated to reach USD 29.62 billion by 2027. The innovation in the manufacturing of respiratory devices has been fueled owing to the increasing prevalence of respiratory diseases.

Patients who are suffering from asthma & chronic obstructive pulmonary diseases arelooking for better precision in drug deliveryand this has led to a rise in the adoption of respiratory devices. According to WHO, the chronic obstructive pulmonary disease is a significanthealth concern and one of the major causes of death across the globe.

Therefore, technology plays a huge role in this as technologically advanced medical devicesalong with effective drugs have become key to the management of chronic obstructive pulmonary diseases and other respiratory disorders. Numerous new drugs have been launched and are still being launched for the management of COPD and other respiratory diseases in the last decade. Furthermore, owing to the rise in the number of products in the pipeline, the respiratory devices market will witness huge scope for expansion specifically as the demand for respiratory devices increased amid the COVID-19 outbreak.

Some of the innovations in Respiratory devices include: Innovations in respiratory rate monitoring Masimo provides a complete portfolio of oxygenation & capnography solutions. It comes with industry-leading pulse oximetry & CO-oximetry technologies and both sidestream & mainstream capnography options. These solutions help in addressing the challenges of alveolar ventilation monitoring in virtually all care areas.

Masimo’s rainbow Acoustic Monitoring renders a noninvasive, as well as continuous easy-to-use & reliable monitoring solution that provides the advantage of higher patient compliance. In addition to this, continuous monitoring of SpO2 as well as acoustic respiration rate & other physiologic parameters on a single Masimo Pulse CO-Oximeter enables well-rounded patient assessment and provides clinicians with more data leading them to make informed care decisions

. Active Humidification & Breathing Circuits Teleflexis a company that continuously strives for improving the standard of respiratory care via progressive medical technologies that are designed specifically for meeting the needs& requirements of the respiratory specialist. The company’s Hudson RCI branded respiratory therapy portfolio renders a comprehensive range of respiratory solutions for active humidification for both invasive and non-invasive ventilation, oxygen therapy,and aerosol therapy.

Teleflex’s Hudson RCI Neptune Heated Humidifieroffers optimal humidification levels for a variety of patients. This includes neonates to adults with both invasive & noninvasive ventilation. Teleflex is also in the process of introducing ConchaSmart Technology which consists of

best-in-class features that include an Auto Settings mode, expanded temperature range,and low water notification. Another company that provides the healthcare industry with a humidified high-flow system for treating patients across the care continuum is Fisher & Paykel Healthcare.

The company offers Airvo2. It is a humidified high-flow system.This system has been proven to be effective in patients who haveacute hypoxemic respiratory failure. It is also implemented for postoperative respiratory support, for immunocompromised patients with acute hypoxemic respiratory failure, post-extubation respiratory support, & for patients with COPD.

Intelligent Ventillation Modes Hamilton Medicalis a company that aims to support clinicians by rendering Intelligent Ventilation solutions which improve both patient safety as well as comfort. It aims to provide solutions that are easy to use & increase the efficiency of care. Hamilton’s Medical Intelligent ventilation modes Adaptive Support Ventilation (ASV) and INTELLiVENT-ASV adapt ventilation breath by breath for active and passive patients, 24 hours a day from intubation to extubation and it automatically employs lung-protective strategies for minimizing complications such as AutoPEEP & volutrauma/barotrauma.

They encourage the patient to breathe spontaneously within the rules of this lung-protective strategy and ASV adjusts respiratory rate, tidal volume as well as inspiratory time continuously based on the lung mechanics and effort of the patient.

Another company that offers high-quality ventilators is Smith Medical. Smith Medical offers Pneupac transport ventilators which are highly trusted by first-responders, emergency medicine physicians ¶medics across the globe. While Pneupac ventilators are manufactured to the industry's highest standards of quality, reliability & durability, these ventilators are backed with comprehensive service & support programsthat are designed with an aim to maintain peak operation.

Oxygen Therapy A system that delivers oxygen both efficiently as well as effectively is highly critical when a patient requires oxygen therapy. As an innovator of oxygen technology & portable oxygen equipment for enhancing patient lives, Inogen believes that it is highly imperative to present sound, evidenced-based data for supporting the use of the company’s oxygen therapy devices.

It has completed as well as published more clinical data surrounding the Inogen One oxygen system than any other available oxygen therapy product. Inogen’s ‘Inogen One portable oxygen concentrator makes sure that oxygen is delivered within the first 400 milliseconds of inspiration, and this is where oxygen has the most effect on lung gas exchange.

The company is dedicated towards the designing, developing, and manufacturing of clinically efficacious oxygen technologies. The Inogen One POC is not only lightweight but also easy to use, making breathing easier. The road ahead Organizations operating in the respiratory devices market are mainly focusing on strategic collaborations in order to address the needs and requirements of an expanding patient pool.

Also, there is a huge focus on innovations and USFDA approval among players in this sector. Key players are mainly focusing on the expansion of their global footprint since they expect approvals from regulatory authorities, other than aiming at a competitive advantage.

© 2025 India Pharma Outlook. All Rights Reserved.